A dengue receptor as possible genetic marker of vector competence in Aedes aegypti by Mercado-Curiel, Ricardo F et al.
BioMed  Central
Page 1 of 15
(page number not for citation purposes)
BMC Microbiology
Open Access Research article
A dengue receptor as possible genetic marker of vector 
competence in Aedes aegypti
Ricardo F Mercado-Curiel1, William C Black IV2 and Maria de L Muñoz*1
Address: 1Department of Genetics and Molecular Biology, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional. 
Ave. Instituto Politécnico Nacional 2508 Col San Pedro Zacatenco, C.P. 07360, México, DF, México and 2Department of Microbiology, Colorado 
State University, Fort Collins 80523, USA
Email: Ricardo F Mercado-Curiel - rfmcmx@yahoo.com.mx; William C Black - wcb4@lamar.colostate.edu; Maria 
de L Muñoz* - lmunoz@cinvestav.mx
* Corresponding author    
Abstract
Background: Vector competence refers to the intrinsic permissiveness of an arthropod vector for infection,
replication and transmission of a virus. Notwithstanding studies of Quantitative Trait Loci (QTL) that influence
the ability of Aedes aegypti midgut (MG) to become infected with dengue virus (DENV), no study to date has been
undertaken to identify genetic markers of vector competence. Furthermore, it is known that mosquito
populations differ greatly in their susceptibility to flaviviruses. Differences in vector competence may, at least in
part, be due to the presence of specific midgut epithelial receptors and their identification would be a significant
step forward in understanding the interaction of the virus with the mosquito. The first interaction of DENV with
the insect is through proteins in the apical membrane of the midgut epithelium resulting in binding and receptor-
mediated endocytosis of the virus, and this determines cell permissiveness to infection. The susceptibility of
mosquitoes to infection may therefore depend on their specific virus receptors. To study this interaction in Ae.
aegypti strains that differ in their vector competence for DENV, we investigated the DS3 strain (susceptible to
DENV), the IBO-11 strain (refractory to infection) and the membrane escape barrier strain, DMEB, which is
infected exclusively in the midgut epithelial cells.
Results: (1) We determined the MG proteins that bind DENV by an overlay protein binding assay (VOPBA) in
Ae. aegypti mosquitoes of the DS3, DMEB and IBO-11 strains. The main protein identified had an apparent
molecular weight of 67 kDa, although the protein identified in the IBO-11 strain showed a lower mass (64 kDa).
(2) The midgut proteins recognized by DENV were also determined by VOPBA after two-dimensional gel
electrophoresis. (3) To determine whether the same proteins were identified in all three strains, we obtained
polyclonal antibodies against R67 and R64 and tested them against the three strains by immunoblotting; both
antibodies recognized the 67 and 64 kDa proteins, corroborating the VOPBA results. (4) Specific antibodies
against both proteins were used for immunofluorescent location by confocal microscopy; the antibodies
recognized the basal lamina all along the MG, and cell membranes and intercellular spaces from the middle to the
end of the posterior midgut (pPMG) in the neighborhood of the hindgut. (5) Quantitative analysis showed more
intense fluorescence in DS3 and DMEB than in IBO-11. (6) The viral envelope antigen was not homogeneously
distributed during MG infection but correlated with MG density and the distribution of R67/R64.
Conclusion: In this paper we provide evidence that the 67 kDa protein (R67/R64), described previously as a
DENV receptor, is related to vector competence in Ae. aegypti. Consequently, our results strongly suggest that
this protein may be a marker of vector competence for DENV in Ae. aegypti mosquitoes.
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Background
DENV is a Flavivirus within the Arboviruses class, more
than 500 of which have so far been identified. DENV is
distributed worldwide in tropical and subtropical coun-
tries in association with its mosquito vector Ae. aegypti.
Dengue infection ranges from self-limited asymptomatic
or mild illness (dengue fever, DF) to a severe hemorrhagic
disease (dengue hemorrhagic fever, DHF) that can
progress to dengue shock syndrome (DSS) characterized
by circulatory failure [1].
More than fifty million dengue infection cases occur every
year [2], resulting in approximately 24,000 deaths due to
DSS. In Mexico [3], 45,748 cases of DF and 10,501 of DHF
were reported from 2004 to 2006. Although DEN is the
most common vector-borne viral disease, few studies have
investigated the complex relationship between DENV and
Ae. aegypti through their genetic characteristics.
Transmission of infection depends on DENV virulence,
host immunity and the susceptibility of the mosquito to
infection. Susceptibility will depend on the interaction
between the mosquito and DENV: the interaction
between midgut (MG) cell membrane receptors and the
virus envelope glycoprotein is the initial step [4] in recep-
tor-mediated endocytosis [5,6]. This essential step deter-
mines cell permissiveness to infection. Furthermore, it is
known that populations of Ae. aegypti differ greatly in
their susceptibility to DENV [7-10] and this variability is
determined by the effects of several genes [11,12]. It has
also been proposed [7] that the infection barriers in the
mosquitoes are the MG infection barrier (MIB), which
prevents DENV infection of MG epithelial cells, and the
MG escape barrier (MEB), which prevents DENV from
leaving the MG and infecting peripheral tissues, limiting
the infection to MG cells. Three Ae. aegypti strains differing
in DENV vector competence were selected: the susceptible
DS3 strain lacks MIB and MEB, so 95–100% of these mos-
quitoes have disseminated infection [13]; the DMEB
strain has MEB, and although 85% of them are infected in
the MG epithelial cells, 27% develop a disseminated
infection [13]; and the refractory strain, IBO-11, has MIB
[14]. Differences in vector competence may, at least in
part, be due to the presence of specific MG epithelial
receptors and their identification would be a significant
step forward in understanding the interaction of the virus
with the mosquito vector with possible implications for
vector surveillance and control of virus transmission.
Fc gamma receptor-mediated entry of infectious DENV
immune complexes into human monocytes/macrophages
is hypothesized to be a key event in the pathogenesis of
DHF [15-18]. However, this mechanism does not explain
virus entry in primary infections or in cells with non-Fc
receptors such as those of mosquitoes [19,20].
Putative non-Fc gamma receptors differ in chemical struc-
ture [21]; proteins [22-34] or glycoproteins [35]; heparan
sulfates [36] and LPS/CD14-associated binding proteins
[37] have been proposed as cellular receptors for DENV.
We have previously shown that the four serotypes of
DENV mainly recognize two proteins with apparent
molecular weights of 80 and 67 kDa [24,29] from Ae.
albopictus C6/36 cells and Ae. aegypti MG. Although a vari-
ety of receptors have been described in many studies, the
mechanism by which the virus enters the cell is unknown.
A study of receptors in the DS3, DMEB and IBO-11 strains
will allow us to determine whether they are related to the
susceptibility of Ae. aegypti to DENV infection and trans-
mission, and consequently whether they may serve as
genetic markers of vector competence. To date, none have
been described. Knowledge of one or more genes respon-
sible for susceptibility will help in designing new control
strategies that may prevent DENV infection and dissemi-
nation in the mosquito vector [38].
Therefore, the objective of this work was to determine
whether DENV receptors from Ae. aegypti MG are related
to vector competence. The aim was to identify the proteins
recognized by DENV in three Ae. aegypti strains that differ
in their susceptibility to infection.
Results
Identification of DENV binding proteins in MG from DS3, 
DMEB and IBO-11 by VOPBA
To determine the apparent molecular weights of DENV-
binding MG proteins from each Ae. aegypti strain, equiva-
lent amounts of MG protein extracts (35 μg) were sepa-
rated by SDS-PAGE, blotted on to PVDF membranes and
analyzed by VOPBA (Figure 1A) using the same specific
antibodies against dengue virus used in our previous
study [29]. In the IBO-11 strain, DENV bound mainly to a
protein of apparent molecular weight about 64 kDa,
whereas in the DS3  and  DMEB  strains the apparent
molecular mass of this protein was 67 kDa. Proteins with
molecular masses of 80 and 57 kDa were also visualized,
as previously described [29], though these bands were not
very strong. Because the IBO-11 strain showed a very faint
band, we repeated the experiment, increasing the protein
concentration approximately 3-fold compared to DMEB
(Figure 1B). The masses of protein loaded on to the gel for
each strain were: 72 μg for DS3, 59 μg for DMEB and 155
μg for IBO-11. DENV recognized the protein with appar-
ent molecular mass of 80 kDa with approximately the
same intensity in all three strains; the 67 kDa protein had
the same molecular weight in the DS3 and DMEB strains,
but in the IBO-11 strain the apparent molecular mass was
64 kDa. As a control for gel loading accuracy, blots were
probed with anti-actin antibody; each specific band on
the membranes was quantified by densitometry and nor-BMC Microbiology 2008, 8:118 http://www.biomedcentral.com/1471-2180/8/118
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malized to actin. The amount of DENV bound to the 67/
64 kDa proteins in each strain varied in the proportions
DMEB: DS3: IBO-11 = 77: 56: 1. These differences may be
due to differences in the amount of MG protein from each
mosquito strain or in their affinity for DENV.
To determine whether the proteins identified by VOPBA
represent one or more different molecules or whether
there are differences among the strains, 300 MGs were
subjected to two-dimensional gel electrophoresis (Figure
2A) and a VOPBA was performed on the gel (Figure 2B).
In the DS3 and DMEB strains, DENV mainly recognized
two protein spots with almost the same apparent molecu-
lar mass of 67 kDa (black arrow). The IBO-11 strain dis-
played the same spots, although the lower one, which was
more evident, probably corresponds to the protein with
apparent molecular mass about 64 kDa. The faint upper
spot may correspond to the protein with molecular mass
of 67 kDa. The isoelectric point of both proteins in the
three strains was about 5.3.
Identification of R67 and R64 in DS3, DMEB and IBO-11 
by immunoblotting
To determine whether the 67 and 64 kDa MG proteins
from the three Ae. aegypti strains are related, we obtained
specific polyclonal antibodies against those proteins from
the DS3 and IBO-11 strains and used them for immunob-
lotting of SDS-PAGE. Both the 67 and 64 kDa proteins
were recognized by the antibodies. Figure 3 shows an
immunoblot with the specific antibody against R64 from
the IBO-11 strain; equivalent results were observed when
we used the other antibodies. The main protein recog-
nized by the antibodies in DS3 and DMEB had an appar-
ent molecular weight of 67 kDa. The IBO-11  strain
displayed a protein with apparent molecular weight of 64
kDa, although the band was very faint, probably because
its relative concentration was lower than in the other two
strains.
Thus, we found that the differences observed by VOPBA
(Figure 1A) were not due to differences in the affinity of
R67 and R64 for DENV, but may have been due to differ-
ences in the amounts of R67 and R64 in MG from each
strain. Each specific band in the membranes was analyzed
by densitometry and normalized to actin as control of the
quantity of protein loaded on to each lane.
Distribution of R67/R64 in Aedes aegypti midgut
To determine the distribution of R67 and R64 along the
MG in the DS3, DMEB and IBO-11 strains, we performed
confocal microscopy on dissected MG, immunofluores-
cently labeled with the specific antibody against those
VOPBA of membranes blotted from SDS-PAGE of MG protein extract from DS3, DMEB and IBO-11 strains Figure 1
VOPBA of membranes blotted from SDS-PAGE of MG protein extract from DS3, DMEB and IBO-11 strains. A. 
35 μg of protein were loaded on each lane; actin was used as control for the amount of protein loaded. B. The amounts of pro-
tein loaded on each lane were: 72 μg for DS3; 59 μg for DMEB; 155 μg for IBO-11.
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proteins (Figure 4). This revealed the distribution of the
proteins between the cells facing the lumen and the basal
lamina (BL) of the epithelium, and from the cardia
through the anterior MG (AMG) and posterior MG
(PMG). The proteins were detected in the BL all along the
MG in all three Ae. aegypti strains (evident in panels 4B,
4D and 4H). In addition, the specific antibody bound to
epithelial cells beside the cell membrane in all strains
from the middle to the end of the PMG (pPMG); in this
region the fluorescence was more intense in DS3  and
DMEB  MGs (4C, 4F) than in IBO-11  MG (4I). These
results suggest a higher density of R67 and R64 in DS3 and
DMEB  MGs. Control MGs stained with pre-immune
serum showed no-fluorescence (results not-shown).
Time-course of DENV infection in Aedes aegypti midgut
We analyzed the time-course of infection all along the MG
in order to determine the density and distribution of
DENV and its binding proteins at the outset of the infec-
tive process.
Mosquitoes were infected via an artificial membrane
feeder and the entire MG was dissected at 5, 13, 26 h and
14 days of cultivation after infection. The MG was exam-
ined from the cardia through the AMG and PMG by con-
focal microscopy after immunofluorescent labeling with
anti-DEN-2 protein E. Figures 5, 6 and 7 correspond to the
DS3, DMEB and IBO-11 strains respectively.
DENV reached the epithelial cells in all strains 5 h after
infection, before the peritrophic matrix (PM) was formed.
The distribution of DENV in the IBO-11 strain was similar
to the other strains until 5 h, but virus density decreased
with incubation time; the fluorescence had very low
intensity at 13 h after infection; and at 26 h and 14 days
after infection it had completely disappeared in 80% of
the analyzed MGs.
In the DS3 and DMEB strains the fluorescence was very
similar in each region analyzed at all times after infection;
the infection increased with time and viral envelope anti-
gen was apparent in the BL from 5 h until 14 days after
Two dimensional gel electrophoresis analysis of proteins from DS3, DMEB and IBO-11 strains Figure 2
Two dimensional gel electrophoresis analysis of proteins from DS3, DMEB and IBO-11 strains. A. Two dimen-
sional gel electrophoresis of DS3, DMEB and IBO-11 protein extracts (300 μg). B. VOPBA of PVDF membranes blotted from 
two dimensional gel electrophograms of MG protein extracts from these strains. Black arrows indicate the dots that were rec-
ognized by DENV.
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infection irrespective of the distribution in epithelial cells
(evident in panel 5J).
We quantified the fluorescence (Figure 8) as mentioned in
methods and noticed that the initial level was very similar
in all three strains. In DS3 and DMEB the maximum level
was very alike, containing no statistically significant dif-
ference after 26 h of infection at pPMG; after 14 days, this
region showed less viral envelope antigen and virus was
observed at the anterior PMG. Virus infection was higher
at this time compare to infection after 5 h (p < 0.05). If we
compare virus infection of IBO-11  strain with DS3  or
DMEB at 13, 26 and 336 h the difference is very evident
(*p < 0.05); contrary to infection at 5 h. Furthermore, if
we compare, infection at 5 h with all times in each strain,
we observe that DS3 and DMEB showed an increase (**p
< 0.05); opposite to the IBO-11 strain where there is an
infection decrease (**p < 0.05).
Importantly, the highest fluorescence intensity observed
in the MG at the beginning of infection (26 h after infec-
tion) was very similar to that observed by immunofluores-
cence assays using anti-R67/R64 antibody. All infected or
non-infected MGs stained with pre-immune serum
showed no-fluorescence (results not-shown).
Discussion
The relationships between DENV and its arthropod vector
Ae. aegypti are crucial, and analysis of host cell responses
to flavivirus infection of mosquito vectors is particularly
important for understanding the maintenance and trans-
mission of the disease. Mosquito populations differ in
their susceptibility to flavivirus development, termed
"vector competence", reflecting the different barriers
encountered by the virus from its entry into the mosquito
to its release in the saliva. Factors such as specific mos-
quito receptors on the epithelial cells as well as differen-
tial viral replication in the mosquito are critical for vector
competence in addition to other genes as has been exhib-
ited by the QTL studies [39]. In the laboratory we have
three mosquito strains with different susceptibilities to
DENV infection (DS3, DMEB and IBO-11) and these have
allowed us to determine whether MG cell receptors for
DENV may be markers of vector competence.
A possible explanation for the wide spectrum of DENV
receptors in host cells may be that different cell types have
been used; alternatively, the reported proteins may not all
be cell membrane components. Increasing evidence
[33,40] suggests that DENV interacts differently with
mammalian and mosquito cells; accordingly, we have
studied the molecules that serve as true DENV receptors in
the MG of Ae. aegypti. We previously showed by VOPBA
[29] that the four serotypes of DENV mainly recognized
two membrane proteins with apparent molecular weights
of 80 (R80) and 67 (R67) kDa in Ae. albopictus C6/36 cells
and Ae. aegypti MG.
Both of these receptors were detected in the MG of strains
DS3, DMEB and IBO-11 in this study, although IBO-11
displayed a protein with a slightly lower apparent molec-
ular weight (64 kDa) in addition to the 67 kDa protein,
and the quantity of R67 was much lower than in the other
two strains. R67 and R64 seem to be the same protein,
because both are recognized by polyclonal anti-R67 and
anti-R64 antibodies from the DS3 and IBO-11 strains. The
size difference was also detected by two dimensional gels
(Figure 2). Munoz et al. [24] and Mercado-Curiel et al.
[29] showed that anti-R67 antibody inhibited DENV
infection more strongly than anti-R80 in C6/36 cells. This
is in agreement with the present results, since R80 was rec-
ognized in all three strains with no apparent change, sug-
gesting that although this protein participates in DENV
binding; its role may be different. It will be necessary
future studies to determine R80 function during mosquito
virus infection. Difference between R67 and R64 will be
the objective of future studies, since they may be attribut-
able to many facts such as post-translational modifica-
tions, different splicing or a deletion in the coding region.
Immunoblotting with the specific anti-R67 or anti-R64 anti- body Figure 3
Immunoblotting with the specific anti-R67 or anti-
R64 antibody. Protein extracts of Ae. aegypti MG from the 
DS3, DMEB and IBO-11 strains were separated by SDS-PAGE, 
transferred to PVDF membranes and immunoblotted with 
the specific anti-R64 antibody from IBO-11. Actin was used as 
control of the amount of protein loaded on each lane. Similar 
results were observed when anti-R67 from IBO-11 or anti-
R67 or anti-R64 from DS3 was used.
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Studies of the vector competence of Ae. aegypti for DENV
are typically qualitative, involving the detection of viral
antigens in the MG and the head. This is the first study to
scan DENV infection and R67 protein distribution thor-
oughly along the entire MG, taking into account that MG
contains morphologically different epithelial cells [41]
with different biochemical characteristics [42,43]. Previ-
ous studies have not determined DENV distribution in
detail; most of them have concerned virus titer (presence
or absence) in the whole mosquito MG [44-49].
Immunofluorescence with the specific anti-receptor antibody Figure 4
Immunofluorescence with the specific anti-receptor antibody. MG dissected from the DS3, DMEB and IBO-11 strains 
were immunolabeled with the specific anti-R67 antibody from IBO-11 and analyzed by confocal microscopy. Strains: DS3 (pan-
els A, B, C), DMEB (panels D, E, F), IBO-11 (panels G, H, I); analyzed region: cardia/AMG (panels A, D, G), aPMG (panels B, E, 
H), pPMG (panels C, F, I). AMG (anterior midgut), aPMG (anterior segment of the posterior midgut), pPMG (posterior seg-
ment of the posterior midgut).
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Time-course of midgut DENV infection in Ae. aegypti DS3 strain Figure 5
Time-course of midgut DENV infection in Ae. aegypti DS3 strain. Immunofluorescent labelling with the specific anti-
body anti-DEN-2 protein E was followed by confocal microscopy. MGs were dissected from DS3 mosquitoes 5, 13, 26 h and 
14 d after infection. Cardia/AMG (panels A, D, G, J), aPMG (panels B, E, H, K), pPMG (panels C, F, I, L).
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Time-course of DENV infection in Ae. aegypti midgut (DMEB strain) Figure 6
Time-course of DENV infection in Ae. aegypti midgut (DMEB strain). Immunofluorescent labeling with the specific 
antibody anti-DEN-2 protein E was followed by confocal microscopy. MGs were dissected from DMEB mosquitoes 5, 13, 26 h 
and 14 d after infection. Cardia/AMG (panels A, D, G, J), aPMG (panels B, E, H, K), pPMG (panels C, F, I L).
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Time-course of DENV infection in Ae. aegypti midgut (IBO-11 strain) Figure 7
Time-course of DENV infection in Ae. aegypti midgut (IBO-11 strain). Immunofluorescent labeling with the specific 
antibody anti-DEN-2 protein E was followed by confocal microscopy. MGs were dissected from IBO-11 mosquitoes 5, 13, 26 h 
and 14 d after infection. Cardia/AMG (panels A, D, G, J), aPMG (panels B, E, H, K), pPMG (panels C, F, I L).
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Time-course of DENV infection in Ae. aegypti midgut Figure 8
Time-course of DENV infection in Ae. aegypti midgut. Viral envelope antigen distribution during the DENV infection 
was analyzed in the MG of the DS3 strain (A); DMEB strain (B); or IBO-11 strain (C) in the Cardia/AMG (anterior midgut), 
aPMG (anterior segment of the posterior midgut), pPMG (posterior segment of the posterior midgut). Values are expressed as 
the mean ± S.E.M. ANOVA followed by All Pairwise Multiple Comparison Procedures (Student-Newman-Keuls Method) (p < 
0.05); n = 4 independent replications included at least 5 mosquitoes for each strain and each infection time point. Values from 
DS3 or DMEB strains were compared with IBO-11 strain at 13, 26 and 336 h in each MG region (*p < 0.05, significantly differ-
ent); Cardia/AMG, aPMG, or pPMG values from DMEB, DS3 or IBO-11 strains at 5 h post-infection were compared with those 
post-infected for 13, 26 and 336 h in the respectively strains (**p < 0.05, significantly different; #p > 0.05, non-significantly dif-
ferent).
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R67/R64 were not homogeneously distributed over the
epithelial cells along the MG in the three strains; they were
mainly present in the cell membrane and behind the
intercellular spaces in the region named pPMG, which
extends from middle to the end of the posterior MG in the
neighborhood of the hindgut. The quantity of R67/R64 in
the pPMG region was noticeably higher in DS3 and DMEB
than in the IBO-11 strain (Figure 4). The receptor distribu-
tion was similar to the distribution of infection at the out-
set. Moreover, we observed a correlation among receptor
abundance, presence of DENV and mosquito strain sus-
ceptibility (Figures 4 and 8).
Analysis of the time course of DENV infection from the
beginning to 14 days gave insight into the earliest events
in DENV infection of the MG in the three strains. MG
infection diminished by 14 days post-infection, as
described previously [47]. We also observed that MGs
from the different strains showed a difference in the
degree of infection, depending on the susceptibility of the
strain. For example, the IBO-11 strain showed almost no
fluorescence after 26 days.
Interestingly, DMEB strain showed increase in infection
up to the 26 h in all the three MG regions infection, hav-
ing the maximal virus accumulation in the pPMG and
then diminished by 336 h post-infection compare to the
susceptible strain DS3 that have the maximal virus accu-
mulation in aPMG at 14 days post-infection. These results
also display a statistically significative MG infection
increase from the first 5 h post-infection to 26 h in DS3
and DMEB strains (**p < 0.05). Moreover, IBO-11 strain
exhibited a significative decrease (**p < 0.05) of MG
infection from 5 to 336 h post-infection. Furthermore,
virus infection of IBO-11 strain was almost completely
abolish (*p < 0.05, Figure 8) compared to DS3 and DMEB
strains from 13 to 336 h post-infection.
Recently, the Ae. aegypti genome has been sequenced [50].
This will facilitate the identification of genes encoding the
R67/R64 DENV receptors, which could be important for
influencing the MG infection barrier (MIB). This is in
agreement with Miller and Mitchell [51], who showed
that susceptibility, depends on multiple genes. They
selected refractory or highly susceptible strains and
obtained progeny with intermediate susceptibility, which
suggests that alleles at vector competence loci act addi-
tively. Bosio et al. [14] proposed a significant additive
genetic effect in MIB and demonstrated that the DENV
titer in the MG and head did not correlate with the rate of
infection. They also showed that the heritability for virus
titer in tissues (MG or head) were almost identical in dif-
ferent strains of Ae. aegypti formosus; and showed that the
amount of virus in the MG did not determine if virus was
disseminated, which hypothetical may be due to the pres-
ence or absence of DENV receptors. In the present study
we also observed similar maximum levels of DENV in the
DS3 and DMEB strains, suggesting that genes that influ-
ence the virus titer have minimal impact on overall vector
competence.
Further studies are needed to explain the fact that the
DMEB strain, which has MEB, showed the presence of
DENV in the BL all along the MG throughout the time
course examined. The lack of infection in peripheral tis-
sues may have been mainly due to the lack of cell recep-
tors, or to additional factors specific to the kind of cell that
allows DENV to infect those organs.
Ae. aegypti seems to be the most vulnerable link in the
transmission chain; at present there is no genetic marker
of vector competence for DENV. Such a marker would be
very important in the design of new mosquito control
strategies, such as campaigns focused on natural popula-
tions that could be easily identified by their high DENV
susceptibility, in order to prevent dengue epidemics.
Conclusion
Our results may suggest that R67/R64 from the Ae. aegypti
MG could be used as a vector competence marker, since
those proteins are the main ones involved in the recogni-
tion of DENV by MG cells. The amount of these proteins
in the MG varied proportionally to mosquito vector com-
petence and their distribution along the MG correlated
with the distribution of DENV infection.
Methods
Virus
DEN-2 Jamaica strain was expanded in Vero cells, purified
from the culture supernatants as previously described
[52,53] and kept frozen at -70°C pending for use. Briefly,
Vero cells were cultured at 37°C, 2% CO2 in Dulbecco's
Modified Eagle's Medium (DMEM; HyClone, Logan,
Utah, USA) supplemented with 5% heat-inactivated fetal
bovine serum (FBS; Gibco BRL, Gaithersburg, MD, USA),
100 units/ml of penicillin and 100 μg/ml of streptomycin.
Vero cells were infected with 0.2 ml of DEN-2 inoculum
with an input MOI of 600 PFU/plate and incubated for 10
days; DEN-2 was purified from the clarified supernatants
by a 30/60% sucrose step gradient. Titers of virus stocks
made in LLC-MK2 cells [52] were 8 × 108 PFU/ml.
Mosquito culture
Mosquitoes (DS3, DMEB and IBO-11 strains) were labo-
ratory-reared and maintained at 28°C and 80% RH with
a 12 h photoperiod using standard mosquito-rearing pro-
cedures [54]. They were fed with blood meals to maintain
the strains and the eggs were collected in water cups con-
taining paper filters.BMC Microbiology 2008, 8:118 http://www.biomedcentral.com/1471-2180/8/118
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Mosquito infection and midgut dissection
Mosquitoes (DS3,  DMEB  and  IBO-11  strains) were
infected via an artificial membrane feeder [55]. Briefly, the
blood meal consisted of equal parts of virus suspension,
washed sheep erythrocytes and FBS in 10% sucrose. It was
incubated at 38°C for 15 min, then placed in membrane
feeders covered with hog gut and maintained at a constant
temperature of 37°C. Mosquitoes (250, 3–4 days old)
were starved of sucrose and deprived of water for 30 hours
prior to blood feeding. They were allowed to feed for 45–
60 minutes. Fully engorged females were selected and
held in the insectary.
The entire MG was dissected from 25 mosquitoes at 5, 13,
26 h and 14 days after feeding. The procedure was carried
out in 10 μl phosphate buffered saline (PBS). The MG was
rinsed twice and resuspended in 10 μl of PBS. MGs were
immunolabeled with a specific antibody against DEN-2
envelope protein E (anti-DEN-2 protein E).
All experiments included control mosquitoes fed with a
blood meal without virus. MGs from non-infected mos-
quitoes were also used to obtain protein extracts and were
examined by immunofluorescence with anti-R67.
DEN-2 affinity chromatography
Purified DEN-2 was bound covalently to 1 g CNBr-acti-
vated Sepharose™ 4B (Amersham Pharmacia Biotech) as
described previously [29]. The DEN-2-Sepharose™ 4B col-
umn was either used immediately or stored in 0.002%
sodium azide at 4°C pending for use.
Protein extracts were obtained by homogenizing MGs
(300/ml from the DS3 and IBO-11 strains) in buffer E (50
mM Tris-HCl, pH 7.2, 1 mM EDTA, 0.05% v/v Triton X-
100) containing a protease inhibitor cocktail (Sigma-
Aldrich P8340). To obtain the soluble proteins, the
homogenate was centrifuged for 10 min at 10,000 rpm at
4°C.
Each MG protein extract (1 mg) was applied to the DEN-
2-Sepharose™ 4B column (1 ml) equilibrated in buffer E
and washed with the same buffer. The DEN-2 binding
proteins were eluted with buffer E containing 0.5 M NaCl.
Fractions of 0.5 ml were collected and the protein content
was monitored by the Bradford method [56]. The retained
and eluted proteins were precipitated with acetone, resus-
pended in a 10 μl buffer E/protease inhibitor cocktail
(Sigma-Aldrich P8340) and analyzed by 10% sodium
dodecylate sulfate polyacrylamide gel electrophoresis
(SDS-PAGE) [57].
Preparation of specific polyclonal antibodies against DEN-
2 protein E, R67 and R64
To obtain specific anti-DEN-2 protein E, 10% SDS-PAGE
was performed with purified DEN-2 and the correspond-
ing 52 kDa band from the silver-stained gel was excised
and used to immunize BALB/c mice as described below.
Proteins retained and eluted from the DEN-2-Sepharose™
4B column were separated by 10% SDS-PAGE. After silver
staining, the 64 or 67 kDa band was excised, cut into small
pieces, suspended in PBS and mixed with an equal vol-
ume of Titer-Max adjuvant (CytRx Vaxcel Inc., Norcross,
GA) to immunize two groups of BALB/c mice and obtain
specific antibodies against R67 or R64 from DS3 or IBO-
11 strain Ae. aegypti MGs.
Pre-immune sera were obtained before immunization.
The mice received a booster fifteen days after the first
immunization. They were bled after thirty days and the
sera were stored at -70°C until use. Negative controls
using pre-immune sera were included in all assays. All
immunofluorescence and immunoblotting results were
reproducible using either anti-R67 or R64 from either DS3
or IBO-11.
Immunofluorescence with anti-DEN-2 protein E and anti-
R67
After the MGs were dissected from the different strains
and different infection times, including non-infected
mosquitoes as negative control; they were fixed for 2 h in
4% p-formaldehyde (Sigma-Aldrich Corporation),
washed with PBS, 0.2% PBT (5% BSA, 0.2% Triton X-100
in PBS), incubated overnight at 4°C with anti-DEN-2 pro-
tein E diluted 1:75 or anti-R67 diluted 1:40, washed with
0.1% PBT (0.1% Triton X-100), incubated for 2 h with
1:500 FITC goat anti/mouse (Zymed Laboratories Inc. S.
San Francisco, CA USA), stained with 1 μg/ml propidium
iodide (Sigma-Aldrich Corporation), and then washed
with 0.1% PBT. Finally, each MG was placed individually
on a glass slide with a Vecta Shield (Vector Laboratories).
All preparations were examined by confocal microscopy
(TCS SP5 Leica Microsystems).
Confocal microscopy analysis
Confocal Image was captured using a Leica confocal
microscope scanning system. The confocal microscope
was set up for all the experiments as follow: speed 400 Hz,
PMT1-746, PMT2-933, potency 1/3 and laser 26%. Fluo-
rescence evaluation was made using a 64× (NA 0.3) objec-
tive. The lens is raised to its maximum specified height.
The detector is secured on the stage and centered grossly
using either laser fluorescent or light. The detector posi-
tion is then adjusted more accurately to achieve maxi-
mum signal intensity by using the microscope's x/y
joystick. The CLSM zoom factor is set from 8 to 32 toBMC Microbiology 2008, 8:118 http://www.biomedcentral.com/1471-2180/8/118
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reduce the beam scan and to focus it into the "sweet spot"
of the detector.
A series of 30 successive sections were recorded along the
optical axis of the microscope over a range of the speci-
men planes with a depth separation of 1 μm for each one
of the three different MG regions (Cardia/AMG, aPMG,
pPMG) and mosquito strains, comprising a total of 3
series of 30 slices. Then each confocal fluorescence images
was divided in areas of 1000 μm2. This was done for every
time and each mosquito strain.
The Leica software (1997–2002, Leica Microsystems Hei-
delberg GmbH) was used to evaluate all images. ANOVA
statistic analysis was conducted for all the data.
Results represent the analysis of at least 20 MGs for each
infection time and for each mosquito strain in four inde-
pendent experiments.
Statistical analysis
The means and standard errors of means (S.E.M.) were
calculated for all groups. The data was subjected to a two-
way analysis of variance (ANOVA) by General Linear
Model followed by All Pairwise Multiple Comparison
Procedures (Student-Newman-Keuls Method) to deter-
mine whether means were significantly different among
them. All P values less than 0.05 were considered to indi-
cate statistical significance. All the statistics were carried
out in SigmaStat 2.03 software and data plotted in Sigma-
Plot 2001.
2D gel electrophoresis
Midguts (300) from each strain were solubilized in 125 μl
of IPG strip rehydration buffer (8 M urea, 2% CHAPS, 10
mM DTT, 0.2% Bio-Lyte) at room temperature and centri-
fuged at 10,000 rpm for 10 min. The resulting superna-
tants, containing approximately 936 μg protein for DS3,
1080 μg for DMEB and 1143 μg for IBO-11, were used to
rehydrate each ReadyStrip IPG, pH range 3–10, 7 cm (Bio-
Rad Laboratories, Hercules, CA, USA) under passive con-
ditions overnight at 4°C in the focusing tray (Mini-
PROTEAN 3 cell). Subsequently, IEF was carried out as
recommended by the manufacturer (2 h at 4000 V with a
gradient until a total of 10000 volt-hour was reached).
The strips were removed from the focusing tray and incu-
bated for 15 min in 1 ml equilibration buffer I (50 mM
Tris-HCl, pH 8.8, 6 M urea, 2% SDS, 30% glycerol, 1%
DTT) and 15 min in equilibration buffer II (6 M urea,
0.375 M Tris-HCl, pH 8.8, 2% SDS, 20% glycerol, 2.5% w/
v iodoacetamide). They were washed with distilled water
and placed on the top of the second dimension gel (10%
SDS-PAGE). Molecular weight markers were applied to
small pieces of chromatography paper and inserted next
to each strip on the top of the gel, then the strips and
markers were sealed with ReadyPrep Overlay Agarose
(0.5% low melting point agarose in 1X Tris/Glycine/SDS
and 0.003% Bromophenol Blue). The second dimension
was developed at a constant 150 V (Mini Protean 3, Bio-
Rad Laboratories, Hercules, CA, USA). The gels were silver
stained or used for 2D VOPBA as described below.
1D and 2D virus overlay protein binding assay (VOPBA)
MG protein extracts (35 μg) from each strain, or 72 μg for
DS3, 59 μg for DMEB  and 155 μg for IBO-11, were
obtained as mentioned above by DEN-2 affinity chroma-
tography and separated by 10% SDS-PAGE. Two dimen-
sional gels were developed with approximately 1000 μg
protein from MGs of each strain. All the gels were blotted
on to polyvinylidine difluoride (PVDF) membranes using
the WetBlot technique (BioRad Laboratories, Hercules,
CA, USA) in transfer buffer (15.6 mM Tris-HCl, 120 mM
glycine, 20% methanol). After transfer was complete,
VOPBA was performed as previously described [24].
Briefly, the membrane was blocked for 1 h at room tem-
perature with 5% skim milk in TBS (100 mM Tris-HCl,
0.15% NaCl), incubated overnight with purified DEN-2,
washed with TTBS (100 mM Tris-HCl, 0.15% NaCl, 0.2%
Tween 20) and incubated overnight with 1:200 anti-DEN-
2 protein E at 4°C. Mouse anti-rat brain actin Mab (gen-
erously provided by Dr. Manuel Hernandez-Hernandez
from the department of Cell Biology, Centro de Investi-
gación y de Estudios Avanzados del IPN, Mexico) diluted
1:50 was also included in the VOPBA from 1D gels. The
epitope recognized by this MAb is conserved among all
actins. After washing with TTBS, the membrane was incu-
bated for 2 h at room temperature with 1:1000 alkaline
phosphatase (AP) labeled goat anti-mouse (Zymed Labo-
ratories Inc. S. San Francisco, CA USA) and the reactive
proteins were visualized by color development with the
chromogenic substrate BCIP/NBT.
Immunoblotting with anti-R67 and anti-R64
MG protein extracts from the DS3, DMEB  and IBO-11
strains were separated by 10% SDS-PAGE, transferred to
PVDF membranes (BioRad Laboratories, Hercules, CA,
USA) and incubated with anti-R67 or anti-R64 diluted
1:75 in TBS (100 mM Tris-HCl, 0.15% NaCl). In addition,
anti-actin antibodies diluted 1:50 in TBS were used. The
membranes were incubated for 2 h at room temperature
with the secondary antibody, AP goat anti-mouse (Zymed
Laboratories Inc., San Francisco, CA, USA) diluted 1:1000,
and color was developed as recommended by the manu-
facturer and described above.
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